RMD ResMed Inc.

ResMed to Announce Third Quarter Fiscal Year 2018 Results

SAN DIEGO--(BUSINESS WIRE)--

ResMed (NYSE: RMD) today announced it will report its third quarter of fiscal year 2018 results on Thursday, April 26, 2018, after the New York Stock Exchange market closes. A press release with ResMed’s results will be issued after 1:00 p.m. US Pacific Time and the company will host a webcast to discuss operating results and future outlook.

The earnings webcast is scheduled to begin at 1:30 p.m. US Pacific Time and the live webcast of the call can be accessed on ResMed's Investor Relations website at investor.resmed.com. Please go to this section of the website and click on the icon for the “Q3 2018 earnings webcast.”

Please note that we do not use outside phone lines to access the earnings call.

International earnings webcast times will be:

Thursday, April 26, 9:30 p.m. London

Friday, April 27, 6:30 a.m. Sydney

A replay of the earnings webcast will be accessible on our website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately two hours after the webcast and will be accessible from April 26, 2018, until May 10, 2018, at:

US: +1 800-585-8367

Outside US: +1 416-621-4642

Passcode: 7899017

About ResMed

ResMed (NYSE: RMD) (ASX: RMD), a world-leading connected health company with more than 4 million cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions. Its 6,000-member team strives to improve patients’ quality of life, reduce the impact of chronic disease and save healthcare costs in more than 120 countries. ResMed.com | Facebook | Twitter | LinkedIn

EN
29/03/2018

Underlying

RMDResMed Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ResMed Inc.

Free Trial
RMD RESMED INC.

ResMed Inc: 1 director

A director at ResMed Inc sold 2,000 shares at 260.220USD and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

03/05/26 March 5, 2026 1 EN
 PRESS RELEASE
Free
RMD RESMED INC.

Resmed’s Global Sleep Survey Reveals Sleep is One of the Top Health Pr...

Resmed’s Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach Insights from 30,000 people across 13 countries show global sleep health awareness is growing, yet an action gap remains  53% of people surveyed rank sleep as the most important behavior for a long, healthy life, ahead of diet and exercise.Over half of respondents get quality sleep on only four nights a week or less.While 66% of people surveyed say they would seek medical help for ongoing sleep issues, just 23% actually do. SAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) -- ...

March 3, 2026 1 EN
 PRESS RELEASE
Free
RMD RESMED INC.

Resmed Expands U.S. Operations with New Distribution Center in Greenwo...

Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana Center to Create Local Jobs and Strengthen U.S. Healthcare Supply Resilience SAN DIEGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, is opening a new distribution center in Greenwood, Indiana. Scheduled to begin operations in 2027, the center will expand Resmed’s U.S. presence and strengthen the company's distribution capacity to better serve patients and providers across North America. The...

February 24, 2026 1 EN
 PRESS RELEASE
Free
RMD RESMED INC.

Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 20...

Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026 Revenue increased by 11% to $1.4 billion; up 9% on a constant currency basis Gross margin up 320 bps to 61.8%; non-GAAP gross margin up 310 bps to 62.3%Income from operations increased 18%; non-GAAP income from operations up 19%Diluted earnings per share of $2.68; non-GAAP diluted earnings per share of $2.81Operating cash flow of $340 million Note: A webcast of Resmed’s conference call will be available at 4:30 p.m. ET today at  SAN DIEGO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Resmed Inc. (NYSE: RMD, ASX: RMD) today an...

January 29, 2026 1 EN
 PRESS RELEASE
Free
RMD RESMED INC.

Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 20...

Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026 SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2026 on Thursday, January 29, 2026, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details:•Location:•Date:Thursday, January 29, 2026•Time:1:30 p.m. PST /...

January 8, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch